Liquid biopsy-based ctDNA mutation degree analysis method and device, ctDNA performance analysis device

An analysis device and liquid biopsy technology, applied in the field of biomedicine, can solve problems such as impracticability, and achieve the effects of improving screening efficiency and accuracy, assisting early diagnosis, and high sensitivity

Active Publication Date: 2021-10-08
臻和(北京)生物科技有限公司 +2
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It can be seen that in the early screening detection using DNA mutation as a marker, it is not feasible to realize it by PCR method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liquid biopsy-based ctDNA mutation degree analysis method and device, ctDNA performance analysis device
  • Liquid biopsy-based ctDNA mutation degree analysis method and device, ctDNA performance analysis device
  • Liquid biopsy-based ctDNA mutation degree analysis method and device, ctDNA performance analysis device

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0063] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the specific implementation manners of the present invention will be described below with reference to the accompanying drawings. Obviously, the accompanying drawings in the following description are only some embodiments of the present invention, and those skilled in the art can obtain other accompanying drawings based on these drawings and obtain other implementations.

[0064] In the first embodiment of the present invention, a method for analyzing the degree of mutation of ctDNA based on liquid biopsy, such as figure 1 As shown, including: S10 capture and sequence the plasma sample to be tested according to the pre-created gene mutation panel to obtain a FASTQ file, the cfDNA in the plasma sample to be tested carries a pre-inserted molecular tag; S20 extracts the paired reads in the FASTQ file respectively Molecular tags are stored as uBAM files...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a liquid biopsy-based ctDNA mutation degree analysis method and device, and a ctDNA performance analysis device, wherein the mutation degree analysis method includes: capturing and sequencing a plasma sample to be tested to obtain a FASTQ file; extracting molecular tags in paired reads respectively And store it as uBAM file; compare the gene sequence of the FASTQ file with the reference genome and deduplicate, and merge it with the uBAM file to obtain a BAM file containing molecular tags; aggregate and deduplicate the reads in the BAM file; In the gene mutation panel area, the original mutation set of the sample is obtained, and the gene mutation parameters in it are counted; the original mutation set of the sample is filtered, and the gene mutation parameters of each sample are counted; for the gene mutation parameters of the sample, the mutation of the plasma sample to be detected To improve the sensitivity of ctDNA mutation detection.

Description

technical field [0001] The invention relates to the field of biomedical technology, in particular to a liquid biopsy-based ctDNA mutation degree analysis method and device, and a ctDNA performance analysis device. Background technique [0002] Early screening, early diagnosis, and timely treatment are effective ways to reduce cancer mortality. The European Society for Medical Oncology (ESMO) pointed out that the incidence and mortality of cancer in Western countries are decreasing year by year, mainly due to early screening of cancer, early benign adenoma resection and early treatment of cancer lesions. Discovering and utilizing tumor-specific biomarkers, relying on high-precision detection and analysis methods, targeting the organ of tumor origin and implementing treatment in the early stage of tumor occurrence is a key factor to improve the effect of tumor treatment and prolong the life of patients. Early screening and diagnosis of tumors has far-reaching social and econo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G16B20/50G16B50/30G16B40/00
CPCG16B20/50G16B40/00G16B50/30
Inventor 李庆原谢泓禹刘异倩刘小莉洪媛媛王小庆韩天澄杨顺莉于佳宁陈维之何骥杜波
Owner 臻和(北京)生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products